UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Risk factors, diagnosis, prognosis and treatment of autism

Frontiers in bioscience (Landmark. Print), 2020-06, Vol.25 (9), p.1682-1717

2020

Volltextzugriff (PDF)

Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors

Gene, 2022-03, Vol.813, p.146101-146101, Article 146101

2022

Volltextzugriff (PDF)

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients

Scientific reports, 2021-04, Vol.11 (1), p.8833-8833, Article 8833

2021

Volltextzugriff (PDF)

Studying carrier frequency of spinal muscular atrophy in the State of Qatar and comparison to other ethnic groups: Pilot study

Molecular genetics & genomic medicine, 2023-12, Vol.11 (12), p.e2184-n/a

2023

Volltextzugriff (PDF)

Clinical exome sequencing in 509 Middle Eastern families with suspected Mendelian diseases: The Qatari experience

American journal of medical genetics. Part A, 2019-06, Vol.179 (6), p.927-935

2019

Volltextzugriff (PDF)

In silico and in vivo models for Qatari‐specific classical homocystinuria as basis for development of novel therapies

Human mutation, 2019-02, Vol.40 (2), p.230-240

2019

Volltextzugriff (PDF)

Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review

American journal of medical genetics. Part A, 2022-01, Vol.188 (1), p.116-129

2022

Volltextzugriff (PDF)

Effects of consanguinity in a cohort of subjects with certain genetic disorders in Qatar

Molecular genetics & genomic medicine, 2020-01, Vol.8 (1), p.e1051-n/a

2020

Volltextzugriff (PDF)

Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar

Molecular genetics & genomic medicine, 2020-10, Vol.8 (10), p.e1319-n/a

2020

Volltextzugriff (PDF)

Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies

Hematology (Luxembourg), 2023-12, Vol.28 (1), p.2196866-2196866

2023

Volltextzugriff (PDF)

Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar

Molecular genetics & genomic medicine, 2023-08, Vol.11 (8), p.e2178-n/a

2023

Volltextzugriff (PDF)

Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach

Biomedicines, 2024-01, Vol.12 (1), p.217

2024

Volltextzugriff (PDF)

Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients

Cancer control, 2022-11, Vol.29, p.107327482211402-10732748221140201

2022

Volltextzugriff (PDF)

Exome sequencing identifies novel variants associated with non-syndromic hearing loss in the Iranian population

PloS one, 2023-08, Vol.18 (8), p.e0289247-e0289247

2023

Volltextzugriff (PDF)

Clinical genetics and genomic medicine in Qatar

Molecular genetics & genomic medicine, 2018-09, Vol.6 (5), p.702-712

2018

Volltextzugriff (PDF)

The genetic basis and the diagnostic yield of genetic testing related to nonsyndromic hearing loss in Qatar

Scientific reports, 2024-02, Vol.14 (1), p.4202-4202, Article 4202

2024

Volltextzugriff (PDF)

Impact of timing and severity of COVID-19 infection in pregnancy on intrauterine fetal growth- a registry-based study from Qatar

PloS one, 2023-06, Vol.18 (6), p.e0288004-e0288004

2023

Volltextzugriff (PDF)

Incidence, risk factors, and feto-maternal outcomes of inappropriate birth weight for gestational age among singleton live births in Qatar: A population-based study

PloS one, 2021-10, Vol.16 (10), p.e0258967-e0258967

2021

Volltextzugriff (PDF)

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

Clinical Medicine Insights. Oncology, 2016-01, Vol.2016 (10), p.95-104

2016

Volltextzugriff (PDF)

Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics

Processes, 2023-03, Vol.11 (3), p.939

2023

Volltextzugriff (PDF)

Prevalence, predictors, and outcomes of major congenital anomalies: A population-based register study

Scientific reports, 2023-02, Vol.13 (1), p.2198-2198, Article 2198

2023

Volltextzugriff (PDF)

Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia

International journal of molecular sciences, 2020-03, Vol.21 (7), p.2298

2020

Volltextzugriff (PDF)

Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach

Cancers, 2024-06, Vol.16 (11), p.2017

2024

Volltextzugriff (PDF)

Making Biomarkers Relevant to Healthcare Innovation and Precision Medicine

Processes, 2022-06, Vol.10 (6), p.1107

2022

Volltextzugriff (PDF)

Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9899

2022

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(86)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Risk factors, diagnosis, prognosis and treatment of autism

Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients

Studying carrier frequency of spinal muscular atrophy in the State of Qatar and comparison to other ethnic groups: Pilot study

Clinical exome sequencing in 509 Middle Eastern families with suspected Mendelian diseases: The Qatari experience

In silico and in vivo models for Qatari‐specific classical homocystinuria as basis for development of novel therapies

Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review

Effects of consanguinity in a cohort of subjects with certain genetic disorders in Qatar

Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar

Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies

Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar

Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach

Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients

Exome sequencing identifies novel variants associated with non-syndromic hearing loss in the Iranian population

Clinical genetics and genomic medicine in Qatar

The genetic basis and the diagnostic yield of genetic testing related to nonsyndromic hearing loss in Qatar

Impact of timing and severity of COVID-19 infection in pregnancy on intrauterine fetal growth- a registry-based study from Qatar

Incidence, risk factors, and feto-maternal outcomes of inappropriate birth weight for gestational age among singleton live births in Qatar: A population-based study

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics

Prevalence, predictors, and outcomes of major congenital anomalies: A population-based register study

Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia

Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach

Making Biomarkers Relevant to Healthcare Innovation and Precision Medicine

Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG

Suchergebnisse filtern